People · Operator
Named in public records as an officer, director or promoter · active 2019–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gemelli Biotech Corp. | — | Biotechnology | Series B | $28.5M | $454.3M | 2019 |
Mark Pimentel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Pimentel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Laur | 1 | 2 |
| John A. Neczesny | 1 | 1 |
| Matthew Mitcho | 1 | 1 |
| Oded A. Levy | 1 | 1 |
| Ritish A. Agarwal | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.